vs
Dominari Holdings Inc.（DOMH）与PRECISION BIOSCIENCES INC（DTIL）财务数据对比。点击上方公司名可切换其他公司
PRECISION BIOSCIENCES INC的季度营收约是Dominari Holdings Inc.的1.1倍（$34.2M vs $30.1M），PRECISION BIOSCIENCES INC净利率更高（58.9% vs -438.1%，领先497.0%），PRECISION BIOSCIENCES INC同比增速更快（5261.1% vs 220.4%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs 39.5%）
精准生物科学公司是一家上市的美国临床阶段基因编辑企业，总部位于北卡罗来纳州达勒姆，成立于2006年。该公司依托自主研发的ARCUS基因组编辑平台，专注于开发体内和体外两类基因编辑疗法。
DOMH vs DTIL — 直观对比
营收规模更大
DTIL
是对方的1.1倍
$30.1M
营收增速更快
DTIL
高出5040.7%
220.4%
净利率更高
DTIL
高出497.0%
-438.1%
两年增速更快
DOMH
近两年复合增速
39.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $34.2M |
| 净利润 | $-131.8M | $20.1M |
| 毛利率 | — | — |
| 营业利润率 | -8.9% | 36.6% |
| 净利率 | -438.1% | 58.9% |
| 营收同比 | 220.4% | 5261.1% |
| 净利润同比 | -12426.2% | 213.5% |
| 每股收益（稀释后） | $-6.94 | $2.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHDTIL
| Q4 25 | $30.1M | $34.2M | ||
| Q3 25 | $50.8M | $13.0K | ||
| Q2 25 | $34.1M | $18.0K | ||
| Q1 25 | $8.1M | $29.0K | ||
| Q4 24 | $9.4M | $638.0K | ||
| Q3 24 | $4.0M | $576.0K | ||
| Q2 24 | $6.2M | $49.9M | ||
| Q1 24 | $1.4M | $17.6M |
净利润DOMHDTIL
| Q4 25 | $-131.8M | $20.1M | ||
| Q3 25 | $125.2M | $-21.8M | ||
| Q2 25 | $16.6M | $-23.5M | ||
| Q1 25 | $-32.5M | $-20.6M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $-4.2M | $-16.4M | ||
| Q2 24 | $-6.1M | $32.7M | ||
| Q1 24 | $-5.4M | $8.6M |
营业利润率DOMHDTIL
| Q4 25 | -8.9% | 36.6% | ||
| Q3 25 | -3.1% | -158976.9% | ||
| Q2 25 | -57.0% | -121538.9% | ||
| Q1 25 | -394.6% | -76248.3% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | -79.1% | -3693.6% | ||
| Q2 24 | -44.3% | 48.4% | ||
| Q1 24 | -205.2% | -23.8% |
净利率DOMHDTIL
| Q4 25 | -438.1% | 58.9% | ||
| Q3 25 | 246.4% | -167476.9% | ||
| Q2 25 | 48.7% | -130666.7% | ||
| Q1 25 | -400.5% | -70913.8% | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | -104.2% | -2851.6% | ||
| Q2 24 | -99.1% | 65.6% | ||
| Q1 24 | -398.0% | 48.8% |
每股收益（稀释后）DOMHDTIL
| Q4 25 | $-6.94 | $2.62 | ||
| Q3 25 | $7.27 | $-1.84 | ||
| Q2 25 | $1.12 | $-2.13 | ||
| Q1 25 | $-3.02 | $-2.21 | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $-0.67 | $-2.25 | ||
| Q2 24 | $-1.01 | $4.67 | ||
| Q1 24 | $-0.91 | $1.70 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $115.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $69.4M | $92.2M |
| 总资产 | $112.9M | $154.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMHDTIL
| Q4 25 | $80.5M | $115.6M | ||
| Q3 25 | $176.2M | $44.9M | ||
| Q2 25 | $28.2M | $62.2M | ||
| Q1 25 | $18.9M | $77.2M | ||
| Q4 24 | $8.2M | $86.3M | ||
| Q3 24 | $7.2M | $101.2M | ||
| Q2 24 | $12.1M | $123.6M | ||
| Q1 24 | $7.1M | $137.8M |
股东权益DOMHDTIL
| Q4 25 | $69.4M | $92.2M | ||
| Q3 25 | $210.2M | $16.6M | ||
| Q2 25 | $88.6M | $34.1M | ||
| Q1 25 | $42.4M | $49.3M | ||
| Q4 24 | $39.9M | $56.4M | ||
| Q3 24 | $38.3M | $64.9M | ||
| Q2 24 | $42.4M | $74.7M | ||
| Q1 24 | $47.7M | $37.2M |
总资产DOMHDTIL
| Q4 25 | $112.9M | $154.4M | ||
| Q3 25 | $223.4M | $93.5M | ||
| Q2 25 | $109.3M | $108.9M | ||
| Q1 25 | $52.3M | $124.4M | ||
| Q4 24 | $47.1M | $136.4M | ||
| Q3 24 | $43.4M | $153.3M | ||
| Q2 24 | $49.1M | $165.8M | ||
| Q1 24 | $52.2M | $184.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | $-11.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-11.3M |
| 自由现金流率自由现金流/营收 | — | -32.9% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | -0.56× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOMHDTIL
| Q4 25 | $22.7M | $-11.3M | ||
| Q3 25 | $-4.9M | $-15.3M | ||
| Q2 25 | $-353.0K | $-20.3M | ||
| Q1 25 | $1.2M | $-19.1M | ||
| Q4 24 | $-16.7M | $-58.4M | ||
| Q3 24 | $-4.7M | $-5.9M | ||
| Q2 24 | $1.4M | $-14.9M | ||
| Q1 24 | $-8.6M | $-19.0M |
自由现金流DOMHDTIL
| Q4 25 | — | $-11.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-20.3M | ||
| Q1 25 | — | $-19.1M | ||
| Q4 24 | — | $-58.7M | ||
| Q3 24 | — | $-6.0M | ||
| Q2 24 | — | $-14.9M | ||
| Q1 24 | — | $-19.1M |
自由现金流率DOMHDTIL
| Q4 25 | — | -32.9% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -112627.8% | ||
| Q1 25 | — | -65917.2% | ||
| Q4 24 | — | -9199.8% | ||
| Q3 24 | — | -1033.2% | ||
| Q2 24 | — | -29.9% | ||
| Q1 24 | — | -108.4% |
资本支出强度DOMHDTIL
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 11.1% | ||
| Q1 25 | — | 220.7% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.5% |
现金转化率DOMHDTIL
| Q4 25 | — | -0.56× | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.45× | ||
| Q1 24 | — | -2.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
DTIL
暂无分部数据
